Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 23528024)

Published in Bipolar Disord on March 26, 2013

Authors

Tobias Pagel1, Ross J Baldessarini, Jeremy Franklin, Christopher Baethge

Author Affiliations

1: Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany.

Articles by these authors

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med (2003) 3.99

Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors. Ann Intern Med (2016) 3.95

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76

Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40

International consensus study of antipsychotic dosing. Am J Psychiatry (2010) 3.39

Sharing Clinical Trial Data--A Proposal from the International Committee of Medical Journal Editors. N Engl J Med (2016) 3.06

The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00

Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry (2008) 2.44

Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39

Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. Lancet (2016) 2.25

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol (2009) 2.13

Modern antipsychotic drugs: a critical overview. CMAJ (2005) 1.98

EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry (2002) 1.98

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97

Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry (2003) 1.84

Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res (2005) 1.77

Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry (2002) 1.62

Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry (2002) 1.60

Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leuk Lymphoma (2008) 1.54

New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. J Clin Oncol (2002) 1.53

Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50

Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50

ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology (2006) 1.49

Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 1.49

Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry (2002) 1.49

Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry (2015) 1.49

Publish together or perish: the increasing number of authors per article in academic journals is the consequence of a changing scientific culture. Some researchers define authorship quite loosely. Dtsch Arztebl Int (2008) 1.48

Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom (2013) 1.46

Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46

Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46

Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43

Sharing clinical trial data. BMJ (2016) 1.43

Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns (2011) 1.42

Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord (2010) 1.41

Disability and its treatment in bipolar disorder patients. Bipolar Disord (2007) 1.39

Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36

Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord (2008) 1.35

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol (2003) 1.32

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology (2010) 1.28

Suicide risk and treatments for patients with bipolar disorder. JAMA (2003) 1.26

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial. J Clin Oncol (2007) 1.26

Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry (2006) 1.24

Impact factor--a useful tool, but not for all purposes. Dtsch Arztebl Int (2012) 1.23

Suicide rates in relation to health care access in the United States: an ecological study. J Clin Psychiatry (2006) 1.22

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood (2008) 1.20

Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord (2006) 1.18

Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology (2011) 1.18

Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry (2007) 1.17

Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry (2011) 1.14

McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2008) 1.13

Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2007) 1.12

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood (2014) 1.11

Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord (2004) 1.11

McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2010) 1.11

Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci (2005) 1.11

Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol (2013) 1.10

Advances in development of dopaminergic aporphinoids. J Med Chem (2007) 1.10

Our readers' voice. Letters to the editor are an important component of the discussion of scientific articles, in Deutsches Arzteblatt as in other journals. our correspondence pages reflect a diversity of opinion thanks to the love of debate among our readers--and thanks to a few rules. Dtsch Arztebl Int (2009) 1.08

Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord (2006) 1.08

Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol (2006) 1.07

Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol (2003) 1.06

Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry (2005) 1.06

Transparent texts: authors of scientific articles often have conflicts of interest. It is important for these to be communicated transparently to the readers. Dtsch Arztebl Int (2008) 1.05

Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry (2005) 1.04

Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev (2013) 1.03

The languages of medicine. Dtsch Arztebl Int (2008) 1.02

Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry (2007) 0.99

Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98

Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc (2009) 0.98

Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci (2003) 0.98

Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl) (2002) 0.98

Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry (2003) 0.97

Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther (2002) 0.97

Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord (2005) 0.97

Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J Clin Oncol (2005) 0.96

Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary. Harv Rev Psychiatry (2009) 0.96

Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry (2008) 0.95

Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse (2006) 0.95

Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol (2011) 0.93

Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology (2004) 0.93

Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2013) 0.92

Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol (2005) 0.92

Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord (2008) 0.92

Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92

Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol (2005) 0.92

Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci (2004) 0.92

The virtues of correct citation: careful referencing is important but is often neglected/even in peer reviewed articles. Dtsch Arztebl Int (2011) 0.91

Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord (2007) 0.91

Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol (2006) 0.91

Suicidal risk factors in bipolar I and II disorder patients. J Clin Psychiatry (2011) 0.91

Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord (2004) 0.91

Dopamine D4 receptors: beyond schizophrenia. J Recept Signal Transduct Res (2004) 0.91

Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Ann Pharmacother (2005) 0.91

Scaling behavior of human locomotor activity amplitude: association with bipolar disorder. PLoS One (2011) 0.91

Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord (2008) 0.90

Pretreatment episode count and response to lithium treatment in manic-depressive illness. Harv Rev Psychiatry (2003) 0.90

Continuing medical education in deutsches arzteblatt - an analysis. Dtsch Arztebl Int (2008) 0.90

[German language psychiatry journals in Germany - a quantitative analysis]. Psychiatr Prax (2012) 0.90